https://www.letstalkpeps.com Peptide research, unfiltered. en-us https://www.letstalkpeps.com/articles/glp-1-combinations-asian-t2d-data https://www.letstalkpeps.com/articles/glp-1-combinations-asian-t2d-data Fri, 18 Sep 2026 00:00:00 GMT A 2025 review examines GLP-1 combinations with basal insulin in Asian adults with type 2 diabetes—what the data show on efficacy, safety, and dosing. research https://www.letstalkpeps.com/articles/fda-ai-peptide-vendors https://www.letstalkpeps.com/articles/fda-ai-peptide-vendors Fri, 18 Sep 2026 00:00:00 GMT FDA deploys AI surveillance to flag peptide vendors whose “research use only” labels mask human‑use claims, prompting warning letters and enforcement actions. decision-framework https://www.letstalkpeps.com/articles/oral-peptide-bioavailability-research https://www.letstalkpeps.com/articles/oral-peptide-bioavailability-research Thu, 17 Sep 2026 00:00:00 GMT Oral peptide bioavailability is notoriously low. Recent preclinical and formulation research explains why—and what scientists are testing to fix it. pharmacokinetics https://www.letstalkpeps.com/articles/exendin-4-bone-loss-research https://www.letstalkpeps.com/articles/exendin-4-bone-loss-research Wed, 16 Sep 2026 00:00:00 GMT A 2025 preclinical study tested local exendin-4 bone loss prevention around implants. Here is what the animal data found and what remains unknown. guides https://www.letstalkpeps.com/articles/il-31-atopic-dermatitis-itch https://www.letstalkpeps.com/articles/il-31-atopic-dermatitis-itch Tue, 15 Sep 2026 00:00:00 GMT IL-31 and itch drive the misery of atopic dermatitis. Here is what preclinical and clinical research reveals about the neuroimmune pathway and nemolizumab. fundamentals https://www.letstalkpeps.com/articles/emideltide-dsip-fails-compounding https://www.letstalkpeps.com/articles/emideltide-dsip-fails-compounding Tue, 15 Sep 2026 00:00:00 GMT FDA advisory panel rejected emideltide (DSIP) from the 503A compounding list citing safety, route mismatch, and poor characterization. Highlights evidence thresholds. decision-framework https://www.letstalkpeps.com/articles/peptide-fertility-strategies-research https://www.letstalkpeps.com/articles/peptide-fertility-strategies-research Sat, 12 Sep 2026 00:00:00 GMT Peptide fertility strategies are emerging to counter TRT-induced suppression. Here's what a 2025 narrative review found in preclinical and clinical data. decision-framework https://www.letstalkpeps.com/articles/bmj-peptide-safety-conflicts https://www.letstalkpeps.com/articles/bmj-peptide-safety-conflicts Sat, 12 Sep 2026 00:00:00 GMT BMJ reports FDA scientists worry about carcinogenicity, organ toxicity, addiction risks in experimental peptides, and advisory panel industry ties that may skew regulation. decision-framework https://www.letstalkpeps.com/articles/tirzepatide-sleep-apnea-research https://www.letstalkpeps.com/articles/tirzepatide-sleep-apnea-research Fri, 11 Sep 2026 00:00:00 GMT New post-hoc analyses of SURMOUNT-OSA examine tirzepatide and sleep apnea outcomes by baseline characteristics. Here is what the clinical data actually found. research https://www.letstalkpeps.com/articles/bioavailability-barriers-peptides-fail https://www.letstalkpeps.com/articles/bioavailability-barriers-peptides-fail Thu, 10 Sep 2026 00:00:00 GMT Bioavailability barriers stop most therapeutic peptides from reaching targets. Preclinical research reveals why—and what scientists are testing. pharmacokinetics https://www.letstalkpeps.com/articles/peptide-coupled-red-blood-cells-ms https://www.letstalkpeps.com/articles/peptide-coupled-red-blood-cells-ms Wed, 09 Sep 2026 00:00:00 GMT A 2025 PNAS study tested peptide-coupled red blood cells in multiple sclerosis models. Here is what the preclinical data show about tolerance induction. guides https://www.letstalkpeps.com/articles/gene-encoded-micropeptides https://www.letstalkpeps.com/articles/gene-encoded-micropeptides Wed, 09 Sep 2026 00:00:00 GMT Review uncovers gene‑encoded micropeptides from sORFs in lncRNAs, circRNAs and UTRs as functional regulators and emerging therapeutic targets in cancer and immunity research https://www.letstalkpeps.com/articles/exendin-4-brain-injury-research https://www.letstalkpeps.com/articles/exendin-4-brain-injury-research Tue, 08 Sep 2026 00:00:00 GMT A 2025 preclinical study tested exendin-4 brain injury protection in a fetal inflammatory model. Here is what the data found and what remains unknown. fundamentals https://www.letstalkpeps.com/articles/antidiabetic-drugs-parkinsons-research https://www.letstalkpeps.com/articles/antidiabetic-drugs-parkinsons-research Sun, 06 Sep 2026 00:00:00 GMT A Bayesian meta-analysis compared antidiabetic drugs for Parkinson's disease risk. Here's what the preclinical and clinical evidence actually shows. fundamentals https://www.letstalkpeps.com/articles/bpc-157-pharmacokinetics-research https://www.letstalkpeps.com/articles/bpc-157-pharmacokinetics-research Thu, 03 Sep 2026 00:00:00 GMT BPC-157 pharmacokinetics pose real formulation challenges. Here is what preclinical and early translational research shows about this investigational peptide. pharmacokinetics https://www.letstalkpeps.com/articles/oral-gnrh-antagonists-uterine-fibroids https://www.letstalkpeps.com/articles/oral-gnrh-antagonists-uterine-fibroids Wed, 02 Sep 2026 00:00:00 GMT Oral GnRH antagonists are approved for uterine fibroids. See what clinical evidence shows about how they work and what remains uncertain. guides https://www.letstalkpeps.com/articles/diabetic-heart-damage-preclinical-studies https://www.letstalkpeps.com/articles/diabetic-heart-damage-preclinical-studies Tue, 01 Sep 2026 00:00:00 GMT Diabetic heart damage is the focus of new rat studies probing insulin signaling and post-PCI failure. Here is what the preclinical data found. fundamentals https://www.letstalkpeps.com/articles/cagrisema-weight-loss-rct-data https://www.letstalkpeps.com/articles/cagrisema-weight-loss-rct-data Mon, 31 Aug 2026 00:00:00 GMT A 2025 meta-analysis pooled RCT data on cagrisema weight loss. Here is what the evidence found and what remains uncertain. decision-framework https://www.letstalkpeps.com/articles/exendin-4-anxiety-research https://www.letstalkpeps.com/articles/exendin-4-anxiety-research Sun, 30 Aug 2026 00:00:00 GMT Exendin-4 reduced anxiety-like behaviors in stressed mice by acting on GLP-1 receptors in the brain. Here is what the preclinical research actually found. fundamentals https://www.letstalkpeps.com/articles/tirzepatide-blood-pressure-cardiometabolic https://www.letstalkpeps.com/articles/tirzepatide-blood-pressure-cardiometabolic Fri, 28 Aug 2026 00:00:00 GMT New meta-analyses examine tirzepatide blood pressure, weight, and cardiovascular risk markers. Here's what the studies found. research https://www.letstalkpeps.com/articles/antimicrobial-peptide-delivery-efficacy https://www.letstalkpeps.com/articles/antimicrobial-peptide-delivery-efficacy Thu, 27 Aug 2026 00:00:00 GMT Antimicrobial peptides show promise against drug-resistant bacteria, but delivery barriers limit their reach. Here's what preclinical research reveals. pharmacokinetics https://www.letstalkpeps.com/articles/oral-glp-1-agonists-phase-ii https://www.letstalkpeps.com/articles/oral-glp-1-agonists-phase-ii Wed, 26 Aug 2026 00:00:00 GMT A phase II trial of oral GLP-1 agonists found significant weight loss without injections. Here is what the VCT220 data show and what questions remain. guides https://www.letstalkpeps.com/articles/pth-1-34-periodontitis-research https://www.letstalkpeps.com/articles/pth-1-34-periodontitis-research Tue, 25 Aug 2026 00:00:00 GMT PTH 1-34 reduced bone loss and shifted immune balance in a preclinical periodontitis model. Here is what the research actually found and what remains unknown. fundamentals https://www.letstalkpeps.com/articles/real-world-drug-data-studies https://www.letstalkpeps.com/articles/real-world-drug-data-studies Mon, 24 Aug 2026 00:00:00 GMT Real-world drug data from five 2025 studies reveals how semaglutide, lecanemab, and upadacitinib perform outside controlled trials—and what the gaps mean. decision-framework https://www.letstalkpeps.com/articles/glp-1-medicines-beyond-weight-loss-6 https://www.letstalkpeps.com/articles/glp-1-medicines-beyond-weight-loss-6 Sun, 23 Aug 2026 00:00:00 GMT GLP-1 medicines do more than cut calories. Explore what preclinical and clinical research reveals about their weight-loss-independent actions. fundamentals https://www.letstalkpeps.com/articles/glp-1-agonists-new-research https://www.letstalkpeps.com/articles/glp-1-agonists-new-research Sat, 22 Aug 2026 00:00:00 GMT GLP-1 agonists are showing up in surprising clinical contexts. Here's what new research shows about epilepsy, stoma care, and heart signals. decision-framework https://www.letstalkpeps.com/articles/romiplostim-what-research-shows https://www.letstalkpeps.com/articles/romiplostim-what-research-shows Fri, 21 Aug 2026 00:00:00 GMT Romiplostim research in immune thrombocytopenia: what a 2025 systematic review and meta-analysis found about efficacy and safety signals. research https://www.letstalkpeps.com/articles/peptide-delivery-stimuli-responsive-systems https://www.letstalkpeps.com/articles/peptide-delivery-stimuli-responsive-systems Thu, 20 Aug 2026 00:00:00 GMT Explore how stimuli-responsive peptide delivery systems control release timing, reduce burst effects, and improve pharmacokinetics in preclinical research. pharmacokinetics https://www.letstalkpeps.com/articles/anti-cgrp-antibodies-migraine-research https://www.letstalkpeps.com/articles/anti-cgrp-antibodies-migraine-research Wed, 19 Aug 2026 00:00:00 GMT Anti-CGRP antibodies are reshaping migraine care. See what a 2025 retrospective cohort study found about treatment persistence and adherence. guides https://www.letstalkpeps.com/articles/glp-1-medicines-beyond-weight-loss https://www.letstalkpeps.com/articles/glp-1-medicines-beyond-weight-loss Tue, 18 Aug 2026 00:00:00 GMT GLP-1 medicines do more than shrink waistlines. Explore the weight-loss-independent actions researchers are studying in heart, liver, and immune health. fundamentals https://www.letstalkpeps.com/articles/glp-1-agonists-epilepsy-research https://www.letstalkpeps.com/articles/glp-1-agonists-epilepsy-research Mon, 17 Aug 2026 00:00:00 GMT GLP-1 agonists meet epilepsy: what a 2025 clinical study found about safety and efficacy in adults with obesity, type 2 diabetes, and seizure disorders. decision-framework https://www.letstalkpeps.com/articles/hirudin-peptide-research-explained-6 https://www.letstalkpeps.com/articles/hirudin-peptide-research-explained-6 Sun, 16 Aug 2026 00:00:00 GMT Discover what preclinical studies reveal about hirudin, a natural peptide, and how it may protect kidneys from uric acid-induced injury via NF-κB signaling. fundamentals https://www.letstalkpeps.com/articles/glp-1-analogues-high-output-stoma-research https://www.letstalkpeps.com/articles/glp-1-analogues-high-output-stoma-research Sat, 15 Aug 2026 00:00:00 GMT GLP-1 analogues are being studied for high-output stomas. Here's what a 2025 narrative review found about mechanisms, evidence, and open questions. decision-framework https://www.letstalkpeps.com/articles/new-peptides-what-research-shows https://www.letstalkpeps.com/articles/new-peptides-what-research-shows Fri, 14 Aug 2026 00:00:00 GMT New peptides are reshaping research in 2025. Explore what clinical studies show about LTI-03, zenagamtide, eptinezumab, and more. research https://www.letstalkpeps.com/articles/burst-release-peptide-delivery-timing https://www.letstalkpeps.com/articles/burst-release-peptide-delivery-timing Thu, 13 Aug 2026 00:00:00 GMT Burst release can undermine peptide therapies. Learn what preclinical research reveals about controlling drug timing in modern delivery systems. pharmacokinetics https://www.letstalkpeps.com/articles/inhaled-peptides-ipf-research https://www.letstalkpeps.com/articles/inhaled-peptides-ipf-research Wed, 12 Aug 2026 00:00:00 GMT Inhaled peptides for IPF are entering clinical trials. Here's what early research on LTI-03 and lung biology actually found, explained clearly. guides https://www.letstalkpeps.com/articles/hirudin-peptide-research-explained https://www.letstalkpeps.com/articles/hirudin-peptide-research-explained Tue, 11 Aug 2026 00:00:00 GMT Discover what preclinical studies reveal about hirudin, a natural peptide, and how it may protect kidneys from uric acid injury via NF-κB signaling. fundamentals https://www.letstalkpeps.com/articles/glp-1-analogues-high-output-stoma https://www.letstalkpeps.com/articles/glp-1-analogues-high-output-stoma Mon, 10 Aug 2026 00:00:00 GMT GLP-1 analogues are being studied for high-output stoma management. Here's what the latest narrative review evidence actually shows. decision-framework https://www.letstalkpeps.com/articles/n-methylation-peptide-conformation-binding-6 https://www.letstalkpeps.com/articles/n-methylation-peptide-conformation-binding-6 Sun, 09 Aug 2026 00:00:00 GMT Learn how backbone N-methylation reshapes peptide structure and boosts protein binding, based on preclinical chemistry research. Fundamentals explained. fundamentals https://www.letstalkpeps.com/articles/decision-frameworks-reading-new-drug-data-5 https://www.letstalkpeps.com/articles/decision-frameworks-reading-new-drug-data-5 Sat, 08 Aug 2026 00:00:00 GMT Learn decision frameworks for reading new drug data across cancer, metabolic, and neurological research—without falling for hype or missing real signals. decision-framework https://www.letstalkpeps.com/articles/semaglutide-liver-disease-research https://www.letstalkpeps.com/articles/semaglutide-liver-disease-research Fri, 07 Aug 2026 00:00:00 GMT New meta-analysis data on semaglutide and metabolic liver disease explained. What placebo-controlled trials found—and what remains unknown. research https://www.letstalkpeps.com/articles/peptide-delivery-nanotech-solutions https://www.letstalkpeps.com/articles/peptide-delivery-nanotech-solutions Thu, 06 Aug 2026 00:00:00 GMT Peptide delivery is transformed by nanoarchitectures and stimuli-responsive systems. Explore what preclinical research reveals about bioavailability challenges. pharmacokinetics https://www.letstalkpeps.com/articles/peptide-hydrogels-corneal-repair https://www.letstalkpeps.com/articles/peptide-hydrogels-corneal-repair Wed, 05 Aug 2026 00:00:00 GMT Peptide hydrogels may help repair stubborn corneal wounds. Learn what preclinical research reveals about self-assembling biomimetic peptide hydrogels. guides https://www.letstalkpeps.com/articles/n-methylation-peptide-conformation-binding https://www.letstalkpeps.com/articles/n-methylation-peptide-conformation-binding Tue, 04 Aug 2026 00:00:00 GMT Learn how backbone N-methylation reshapes peptide structure and improves protein binding, based on preclinical chemistry research. fundamentals https://www.letstalkpeps.com/articles/decision-frameworks-reading-new-drug-data https://www.letstalkpeps.com/articles/decision-frameworks-reading-new-drug-data Mon, 03 Aug 2026 00:00:00 GMT Decision frameworks help you understand what recent clinical trials on peptides and drugs actually found—and what the evidence really means for research. decision-framework https://www.letstalkpeps.com/articles/glp-1-obesity-inflammation-link https://www.letstalkpeps.com/articles/glp-1-obesity-inflammation-link Sun, 02 Aug 2026 00:00:00 GMT GLP-1 receptor agonists may connect obesity and inflammation in arthritis and psoriasis. Here's what the latest research actually found. fundamentals https://www.letstalkpeps.com/articles/treatment-trade-offs-weigh-options https://www.letstalkpeps.com/articles/treatment-trade-offs-weigh-options Sat, 01 Aug 2026 00:00:00 GMT Explore treatment trade-offs across six therapy areas—from Cushing's syndrome to migraine—using real study findings to guide smarter conversations with your doctor. decision-framework https://www.letstalkpeps.com/articles/semaglutide-research-findings-explained https://www.letstalkpeps.com/articles/semaglutide-research-findings-explained Fri, 31 Jul 2026 00:00:00 GMT What does recent research say about semaglutide? Explore findings on fatty liver, diabetes prevention, and PCOS from clinical and meta-analysis studies. research https://www.letstalkpeps.com/articles/peptide-pharmacokinetics-delivery-bioavailability https://www.letstalkpeps.com/articles/peptide-pharmacokinetics-delivery-bioavailability Thu, 30 Jul 2026 00:00:00 GMT Peptide pharmacokinetics shape how well these molecules reach their targets. Learn what preclinical research reveals about modern delivery strategies. pharmacokinetics https://www.letstalkpeps.com/articles/gipr-agonism-brain-food-intake https://www.letstalkpeps.com/articles/gipr-agonism-brain-food-intake Wed, 29 Jul 2026 00:00:00 GMT New animal research maps the brain regions behind GIPR agonism and food intake regulation. Here's what the science actually found. guides https://www.letstalkpeps.com/articles/glp-1-agonists-obesity-inflammation-link https://www.letstalkpeps.com/articles/glp-1-agonists-obesity-inflammation-link Tue, 28 Jul 2026 00:00:00 GMT GLP-1 agonists may bridge obesity and inflammation in arthritis and psoriasis. Explore what early research says about this emerging connection. fundamentals https://www.letstalkpeps.com/articles/treatment-trade-offs-weigh-new-data https://www.letstalkpeps.com/articles/treatment-trade-offs-weigh-new-data Mon, 27 Jul 2026 00:00:00 GMT Treatment trade-offs explained: what recent clinical studies reveal about efficacy, safety, and decision frameworks for emerging therapies. decision-framework https://www.letstalkpeps.com/articles/should-you-use-peptides-framework https://www.letstalkpeps.com/articles/should-you-use-peptides-framework Mon, 13 Jul 2026 00:00:00 GMT Skip the hype. A structured framework for evaluating whether a given peptide makes sense — evidence tier, sourcing, regulatory status, and risk. decision-framework https://www.letstalkpeps.com/articles/peptides-vs-proteins-size-function https://www.letstalkpeps.com/articles/peptides-vs-proteins-size-function Mon, 13 Jul 2026 00:00:00 GMT Chain length isn't trivia — it dictates synthesis, targeting, and clearance. The practical breakdown of amino acids vs peptides vs proteins. fundamentals https://www.letstalkpeps.com/articles/peptide-pharmacokinetics-essentials https://www.letstalkpeps.com/articles/peptide-pharmacokinetics-essentials Mon, 13 Jul 2026 00:00:00 GMT Why oral bioavailability is often under 1%, why parenteral is the default, and how half-life engineering changes the dosing equation. The PK essentials. pharmacokinetics https://www.letstalkpeps.com/articles/peptide-drug-history-timeline https://www.letstalkpeps.com/articles/peptide-drug-history-timeline Mon, 13 Jul 2026 00:00:00 GMT Insulin to SPPS to recombinant production to GLP-1s. The key milestones that turned peptides into one of pharma's fastest-growing categories. fundamentals https://www.letstalkpeps.com/articles/peptide-boom-whats-driving-it https://www.letstalkpeps.com/articles/peptide-boom-whats-driving-it Mon, 13 Jul 2026 00:00:00 GMT GLP-1 revenue, a maturing pipeline, and the longevity market. A clear-eyed look at the forces behind the peptide surge — and what's signal vs. hype. fundamentals https://www.letstalkpeps.com/articles/peptide-bond-formation-geometry https://www.letstalkpeps.com/articles/peptide-bond-formation-geometry Mon, 13 Jul 2026 00:00:00 GMT Condensation reaction, partial double-bond character, planar rigidity, N-to-C directionality. The structural fundamentals that govern every peptide. fundamentals https://www.letstalkpeps.com/articles/bioactive-peptides-functional-classification https://www.letstalkpeps.com/articles/bioactive-peptides-functional-classification Mon, 13 Jul 2026 00:00:00 GMT Antimicrobial, antihypertensive, antioxidant, immunomodulatory — a functional map of bioactive peptides and what determines a sequence's class. fundamentals https://www.letstalkpeps.com/articles/retatrutide-what-the-trials-show https://www.letstalkpeps.com/articles/retatrutide-what-the-trials-show Sun, 05 Jul 2026 00:00:00 GMT The triple-agonist everyone's whispering about has real, published human RCTs behind it — up to 24.2% weight loss at 48 weeks and dramatic liver-fat drops. Here's what the data say, and what it still can't tell you. research https://www.letstalkpeps.com/articles/evidence-tiers-explained https://www.letstalkpeps.com/articles/evidence-tiers-explained Sat, 27 Jun 2026 00:00:00 GMT Every peptide on this site wears an evidence badge — human-RCT, human, preclinical, or anecdotal. Here's exactly what each one means, and why we refuse to let a rat study cosplay as a clinical trial. guides https://www.letstalkpeps.com/articles/peptides-101-field-guide https://www.letstalkpeps.com/articles/peptides-101-field-guide Sat, 20 Jun 2026 00:00:00 GMT A no-hype orientation to research peptides — what they are, why the evidence is all over the map, and how to tell a human trial from a rat study before you believe a single claim. guides